Jamie Irvine Associate Editor on The Medicine Maker

I write for the diverse audience of the pharma industry, covering everything from exciting research coming out of academia, to new facility announcements, and more. I'm particularly interested in cell and gene therapeutics, as well as the societal impact of medicinal drug development.

Content by Jamie Irvine:

Research Field Drug discovery

Opiate Dreams and Nightmares

| Jamie Irvine | 3 min read

Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior

Research Field Drug discovery

Alzheimer’s Disease: The Winds of Progress

| Jamie Irvine | 10 min read

Howard Fillit shares his views on the historical research lag, the slim successes so far, and the target pathways that offer most hope

Research Field Drug discovery

Honey, I Shrunk the Molecules

| Jamie Irvine | 2 min read

Researchers demonstrate that microRNA-132 can significantly affect different brain cells, with potential implications for Alzheimer’s disease.

Research Field Drug discovery

Lonely Hearts Club

| Jamie Irvine | 4 min read

TUM Researchers create organoid that emulates the development of the human heart

Research Field Drug discovery

Big Problem, Mini Solution

| Jamie Irvine | 6 min read

Researchers have designed a “mini gene” therapy that could hold promise for treating Usher Syndrome Type 1F

Tools & Techniques Drug delivery

Remote Controlled Chemo

| Jamie Irvine | 3 min read

Meet MAPSULES: metal iron-based nanocapsules that deliver targeted chemotherapy to solid tumors

Tools & Techniques Drug delivery

In Search of Lost Memory

| Jamie Irvine | 12 min read

An insight into the complexities of Alzheimer’s disease and the ongoing pursuit for breakthrough therapies

Research Field Drug discovery

Cancer Treatments for Kids

| Jamie Irvine | 5 min read

Day One Bio commits to creating purposeful treatments for children with life-threatening diseases

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register